About Careers MedBlog Contact us

Mortality Risk Similar for Bypass Surgery and Latest Drug-Coated Stents

by Dr. Trupti Shirole on March 22, 2015 at 6:04 AM
Font : A-A+

Mortality Risk Similar for Bypass Surgery and Latest Drug-Coated Stents

Blocked coronary arteries are treated with stents or traditional bypass surgery. Stents are metal mesh tubes that are threaded into the heart through a leg or an arm artery using a catheter and are then expanded to keep a blocked coronary artery open indefinitely. Bypass surgery is an open-heart procedure that involves grafting of arteries or veins harvested from elsewhere in the body like the leg or the arm or from within the chest itself. Cardiologists at NYU Langone Medical Center have now revealed that newer drug-coated stents have similar long-term death rates compared with traditional bypass surgery for patients with more than one diseased coronary artery.

During the study, researchers studied 9,000 patients who underwent percutaneous coronary intervention (PCI) and received the latest stents coated with the drug everolimus to inhibit inflammation and scar tissue growth; compared to a matched sample of over 9,000 patients who underwent bypass surgery instead.


Researchers found that the stent group fared better in the first 30 days, with only half the number of deaths and one-sixth the number of strokes seen in the bypass group. But in contrast to previous studies, the stent group did not seem to fare worse in the longer term. During the period from 30 days to about 3 years on average, the numbers of deaths in the two groups were not significantly different. Patients in the stent group got about 1.5 times the number of heart attacks long-term, compared to the bypass group. But, patients whose stents successfully opened all of their diseased arteries, there was no significant increase in heart attacks.

Dr. Sripal Bangalore, an associate professor in NYU Langone's Leon H. Charney Division of Cardiology, Department of Medicine, who was lead author of the study, said, "The key finding is that there was no greater mortality in the sample of patients receiving the latest generation stents. The gap in apparent mortality risk between bypass and PCI has been getting smaller and smaller as stent technologies have advanced."

The study was published in the New England Journal of Medicine.

Source: Newswise


Recommended Reading

Latest Heart Disease News

Delay in Seeking Care Results in 55% of Cardiac Deaths in India
The first community-based study, published in the journal Lancet, says that delays in seeking care account for nearly 55% of the reported cardiac and stroke deaths in India.
The Surprising Impact of Quit Smoking: 36% Lower Cardiovascular Risk
The study emphasizes the existing proof on the heart disease risks of tobacco smoking and the urgent need to stop smoking among cancer survivors.
 Discovering Genetic Risks for Type of Heart Attack Largely Affecting Younger Women
New study findings provide novel pathophysiological insights involving blood vessel integrity and tissue-mediated coagulation in a type of heart attack in young women.
Unlocking the Crystal Ball: Heart Failure Subtypes Helps Forecast Future Risks!
Recent study identifies five heart failure subtypes with the potential for individual patient risk prediction.
Is CT Scan the Best Way to Predict Heart Disease Risk?
In middle-age patients, CT scan identifies people who may benefit from drugs to decrease heart disease risk, stated study.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Mortality Risk Similar for Bypass Surgery and Latest Drug-Coated Stents Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests